164 related articles for article (PubMed ID: 20015381)
1. RNA interference as a gene silencing therapy for mutant MYOC protein in primary open angle glaucoma.
Li M; Xu J; Chen X; Sun X
Diagn Pathol; 2009 Dec; 4():46. PubMed ID: 20015381
[TBL] [Abstract][Full Text] [Related]
2. Myocilin Gene Mutation Induced Autophagy Activation Causes Dysfunction of Trabecular Meshwork Cells.
Yan X; Wu S; Liu Q; Cheng Y; Zhang J; Wang N
Front Cell Dev Biol; 2022; 10():900777. PubMed ID: 35615698
[TBL] [Abstract][Full Text] [Related]
3. Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma.
Zode GS; Kuehn MH; Nishimura DY; Searby CC; Mohan K; Grozdanic SD; Bugge K; Anderson MG; Clark AF; Stone EM; Sheffield VC
J Clin Invest; 2011 Sep; 121(9):3542-53. PubMed ID: 21821918
[TBL] [Abstract][Full Text] [Related]
4. Human Pro370Leu Mutant Myocilin Induces the Phenotype of Open-Angle Glaucoma in Transgenic Mice.
Cheng Y; Wu S; Yan X; Liu Q; Lin D; Zhang J; Wang N
Cell Mol Neurobiol; 2023 Jul; 43(5):2021-2033. PubMed ID: 36069958
[TBL] [Abstract][Full Text] [Related]
5. Reversal of mutant myocilin non-secretion and cell killing: implications for glaucoma.
Liu Y; Vollrath D
Hum Mol Genet; 2004 Jun; 13(11):1193-204. PubMed ID: 15069026
[TBL] [Abstract][Full Text] [Related]
6. Accumulation of Asn450Tyr mutant myocilin in ER promotes apoptosis of human trabecular meshwork cells.
Yan X; Wu S; Liu Q; Li Y; Zhu W; Zhang J
Mol Vis; 2020; 26():563-573. PubMed ID: 32818018
[TBL] [Abstract][Full Text] [Related]
7. Topical ocular sodium 4-phenylbutyrate rescues glaucoma in a myocilin mouse model of primary open-angle glaucoma.
Zode GS; Bugge KE; Mohan K; Grozdanic SD; Peters JC; Koehn DR; Anderson MG; Kardon RH; Stone EM; Sheffield VC
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1557-65. PubMed ID: 22328638
[TBL] [Abstract][Full Text] [Related]
8. Targeting the ER-autophagy system in the trabecular meshwork to treat glaucoma.
Stothert AR; Fontaine SN; Sabbagh JJ; Dickey CA
Exp Eye Res; 2016 Mar; 144():38-45. PubMed ID: 26302411
[TBL] [Abstract][Full Text] [Related]
9. Non-secretion of mutant proteins of the glaucoma gene myocilin in cultured trabecular meshwork cells and in aqueous humor.
Jacobson N; Andrews M; Shepard AR; Nishimura D; Searby C; Fingert JH; Hageman G; Mullins R; Davidson BL; Kwon YH; Alward WL; Stone EM; Clark AF; Sheffield VC
Hum Mol Genet; 2001 Jan; 10(2):117-25. PubMed ID: 11152659
[TBL] [Abstract][Full Text] [Related]
10. Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.
Yam GH; Gaplovska-Kysela K; Zuber C; Roth J
Am J Pathol; 2007 Jan; 170(1):100-9. PubMed ID: 17200186
[TBL] [Abstract][Full Text] [Related]
11. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants.
Gobeil S; Rodrigue MA; Moisan S; Nguyen TD; Polansky JR; Morissette J; Raymond V
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3560-7. PubMed ID: 15452063
[TBL] [Abstract][Full Text] [Related]
12. A review of genetic and structural understanding of the role of myocilin in primary open angle glaucoma.
Kanagavalli J; Pandaranayaka E; Krishnadas SR; Krishnaswamy S; Sundaresan P
Indian J Ophthalmol; 2004 Dec; 52(4):271-80. PubMed ID: 15693317
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Patil SV; Kaipa BR; Ranshing S; Sundaresan Y; Millar JC; Nagarajan B; Kiehlbauch C; Zhang Q; Jain A; Searby CC; Scheetz TE; Clark AF; Sheffield VC; Zode GS
Sci Rep; 2024 Mar; 14(1):6958. PubMed ID: 38521856
[TBL] [Abstract][Full Text] [Related]
14. Mutated myocilin and heterozygous Sod2 deficiency act synergistically in a mouse model of open-angle glaucoma.
Joe MK; Nakaya N; Abu-Asab M; Tomarev SI
Hum Mol Genet; 2015 Jun; 24(12):3322-34. PubMed ID: 25740847
[TBL] [Abstract][Full Text] [Related]
15. Cross-talk between MYOC p. Y437H mutation and TGF-β2 in the pathology of glaucoma.
Yang Y; Abdulatef ASWA; Zhang L; Jiang H; Zeng Z; Li H; Xia X
Int J Med Sci; 2020; 17(8):1062-1070. PubMed ID: 32410836
[No Abstract] [Full Text] [Related]
16. Mutant myocilin nonsecretion in vivo is not sufficient to cause glaucoma.
Gould DB; Reedy M; Wilson LA; Smith RS; Johnson RL; John SW
Mol Cell Biol; 2006 Nov; 26(22):8427-36. PubMed ID: 16954374
[TBL] [Abstract][Full Text] [Related]
17. Lentiviral mediated delivery of CRISPR/Cas9 reduces intraocular pressure in a mouse model of myocilin glaucoma.
Patil SV; Kaipa BR; Ranshing S; Sundaresan Y; Millar JC; Nagarajan B; Kiehlbauch C; Zhang Q; Jain A; Searby CC; Scheetz TE; Clark AF; Sheffield VC; Zode GS
Res Sq; 2023 Dec; ():. PubMed ID: 38196579
[TBL] [Abstract][Full Text] [Related]
18. Myocilin misfolding and glaucoma: A 20-year update.
Saccuzzo EG; Youngblood HA; Lieberman RL
Prog Retin Eye Res; 2023 Jul; 95():101188. PubMed ID: 37217093
[TBL] [Abstract][Full Text] [Related]
19. Serine to proline mutation at position 341 of MYOC impairs trabecular meshwork function by causing autophagy deregulation.
Yan X; Wu S; Liu Q; Cheng Y; Teng Y; Ren T; Zhang J; Wang N
Cell Death Discov; 2024 Jan; 10(1):21. PubMed ID: 38212635
[TBL] [Abstract][Full Text] [Related]
20. Cystatin a, a potential common link for mutant myocilin causative glaucoma.
Kennedy KD; AnithaChristy SA; Buie LK; Borrás T
PLoS One; 2012; 7(5):e36301. PubMed ID: 22615763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
